| Recent advances in cell penetrating peptide-based anticancer therapies J Habault, JL Poyet Molecules 24 (5), 927, 2019 | 284 | 2019 |
| The anticancer peptide RT53 induces immunogenic cell death E Pasquereau-Kotula, J Habault, G Kroemer, JL Poyet PLoS One 13 (8), e0201220, 2018 | 49 | 2018 |
| Validation of AAC-11-derived peptide anti-tumor activity in a single graft sézary patient-derived xenograft mouse model J Habault, N Thonnart, C Ram-Wolff, M Bagot, A Bensussan, JL Poyet, ... Cells 11 (19), 2933, 2022 | 7 | 2022 |
| Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53 J Habault, A Kaci, E Pasquereau-Kotula, C Fraser, C Chomienne, ... Oncoimmunology 9 (1), 1728871, 2020 | 7 | 2020 |
| Efficient therapeutic delivery by a novel cell-penetrating peptide derived from Acinus J Habault, C Fraser, E Pasquereau-Kotula, M Born-Bony, ... Cancers 12 (7), 1858, 2020 | 6 | 2020 |
| PAK1-Dependent Antitumor Effect of AAC-11‒Derived Peptides on Sézary Syndrome Malignant CD4+ T Lymphocytes J Habault, N Thonnart, E Pasquereau-Kotula, M Bagot, A Bensussan, ... Journal of Investigative Dermatology 141 (9), 2261-2271. e5, 2021 | 4 | 2021 |
| Transcriptional regulation of Acsl1 by CHREBP and NF-kappa B in macrophages during hyperglycemia and inflammation P Thevkar-Nagesh, J Habault, M Voisin, SE Ruff, S Ha, R Ruoff, X Chen, ... Plos one 17 (9), e0272986, 2022 | 3 | 2022 |
| Methods and vaccine compositions to treat cancers J Poyet, J Habault, PLA Marie US Patent App. 17/786,908, 2023 | | 2023 |
| A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer J Habault, JA Schneider, S Ha, R Ruoff, LD Pereira, J Puccini, M Ranieri, ... Molecular Cancer Therapeutics 22 (10), 1166-1181, 2023 | | 2023 |
| AAC-11 survival pathways as therapeutic target in cancer: AAC-11 leucine-zipper domain derived peptides exert potent antitumor effects and exhibit favorable stability … L Jeammet, E Adicéam, J Habault, A Kaci, J Berrou, M Dupont, ... Cancer Research 83 (7_Supplement), 464-464, 2023 | | 2023 |
| A multivalent peptoid conjugate that inhibits therapy-resistant prostate cancer cell proliferation by modulating androgen receptor transcriptional activity J Habault, JA Schneider, S Ha, R Ruoff, J Puccini, D Bar-Sagi, KK Wong, ... Cancer Research 83 (7_Supplement), 3441-3441, 2023 | | 2023 |
| Cell penetrating peptides for intracellular delivery of molecules J Poyet, A Marie-Cardine, J Habault, C Fraser US Patent App. 17/625,006, 2022 | | 2022 |
| Non-human animal models of sézary syndrome A Marie-Cardine, J Poyet, J Habault, A Bensussan, M Bagot US Patent App. 17/424,973, 2022 | | 2022 |
| Anti-tumor effect of anti-apoptosis clone 11 protein-derived peptides on Sézary syndrome malignant CD4+ T lymphocytes J Habault, N Thonnart, E Pasquereau-Kotula, M Bagot, A Bensussan, ... European Journal of Cancer 156, S14, 2021 | | 2021 |
| Développement et caractérisation de l'effet thérapeutique de peptides pénétrants dérivés de la protéine AAC-11 dans le contexte de cancers cutanés et/ou hématologiques. J Habault Université Paris Cité, 2020 | | 2020 |
| Unraveling Codon Usage for Human Papilloma Virus (Hpv) E6 Immune Evasion A Thermou, C Daskalogianni, VT Dinh, M Blondel, R Fahraeus, J Habault Available at SSRN 4828933, 0 | | |
